货号:A1216730 同义名: ACH-4471;ACH-CFDIS
Danicopan是一种口服活性的 factor D抑制剂,对人factor D具有高结合亲和力,Kd 值为 0.54 nM,在阵发性夜间血红蛋白尿症 (PNH) 和非典型溶血性尿毒症综合征 (aHUS) 中阻断补体的替代途径。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | The complement system provides an important defense against bacteria, fungi, and viruses. Complement factor D (CFD) is a specific serine protease that cleaves its unique substrate and is a promising therapeutic target to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). Danicopan (ACH-4471) is selective and orally active small-molecule factor D inhibitor, shows high binding affinity to human Factor D with Kd value of 0.54 nM. ACH-4471 potently inhibited hemolysis with IC50 values ranging from 0.0040 μM to 0.027 μM, and blocked the APC-mediated killing by aHUS patient sera at sub-micromolar concentrations, which indicates ACH-4471 has the potential as oral therapeutics for human diseases driven by the alternative pathway of complement, including aHUS[1]. In a second study in PNH patients with poor response to eculizumab (defined as the need of red blood cell transfusion), ACH-4471 was given as add-on treatment on top of standard eculizumab at three different doses (100, 150, or 200 mg thrice a day)[2]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.72mL 0.34mL 0.17mL |
8.61mL 1.72mL 0.86mL |
17.23mL 3.45mL 1.72mL |
CAS号 | 1903768-17-1 |
分子式 | C26H23BrFN7O3 |
分子量 | 580.408 |
别名 | ACH-4471;ACH-CFDIS;ALXN 2040;ACH-0144471 |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Inert atmosphere,2-8°C |
溶解方案 |
DMSO: 120 mg/mL(206.75 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |